Substance / Medication

Coal tar

Overview

Active Ingredient
coal tar
RxNorm CUI
2635
Labeler: Sincerus Florida, LLCUpdated: 2019-05-14T00:00:00.000ZFull label on DailyMed

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Detailed dosage and administration information is available in the full FDA drug label.

View full prescribing information on DailyMed

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

145 trials linked to this intervention

145
Total Trials
25
Recruiting
61
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Targeting the Cutaneous Microbiota in Atopic Dermatitis by Coal Tar via AHR-Dependent Induction of Antimicrobial Peptides.
Smits Jos P H, Ederveen Thomas H A, Rikken Gijs et al. · J Invest Dermatol · 2020
PMID: 31344386RCT
Evolution of dissolved organic matter during abiotic oxidation of coal tar--comparison with contaminated soils under natural attenuation.
Hanser Ogier, Biache Coralie, Boulangé Marine et al. · Environ Sci Pollut Res Int · 2015
PMID: 25146121Observational
Comparative evaluation of topical calcipotriol versus coal tar and salicylic acid ointment in chronic plaque psoriasis.
Singh Preeti, Gupta Surabhi, Abidi Afroz et al. · J Drugs Dermatol · 2013
PMID: 23986159Observational
Investigation of sulphur compounds in coal tar using monodimensional and comprehensive two-dimensional gas chromatography.
Machado Maria Elisabete, Caramão Elina Bastos, Zini Cláudia Alcaraz · J Chromatogr A · 2011
PMID: 21215407Observational
Chronic and acute effects of coal tar pitch exposure and cardiopulmonary mortality among aluminum smelter workers.
Friesen Melissa C, Demers Paul A, Spinelli John J et al. · Am J Epidemiol · 2010
PMID: 20702507ObservationalFull text (PMC)
Tolerability and cosmetic acceptability of liquor carbonis distillate (coal tar) solution 15% as topical therapy for plaque psoriasis.
Brouda Irina, Edison Brenda, Van Cott Alicia et al. · Cutis · 2010
PMID: 20486463Observational
Phospholipid-based formulation with improved attributes of coal tar.
Bhatia Amit, Raza Kaisar, Singh Bhupinder et al. · J Cosmet Dermatol · 2009
PMID: 19958432Observational
Comparative quantitative prevalence of Mycobacteria and functionally abundant nidA, nahAc, and nagAc dioxygenase genes in coal tar contaminated sediments.
Debruyn Jennifer M, Chewning Christopher S, Sayler Gary S · Environ Sci Technol · 2007
PMID: 17822112Observational

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Adverse reaction and safety data for this drug is sourced from the FDA-approved label.

View adverse reactions & drug interactions on DailyMed

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Coal tar (substance)
SNOMED CT
53034005
UMLS CUI
C0009137
RxNorm CUI
2635
Labeler
Sincerus Florida, LLC

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
145
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.